(2013) restricted their study period to the years prior to the publication of two observational studies showing an association between use of centrally‐active angiotensin‐converting enzyme inhibitors (CA ACEI) compared to non‐CA ACEIs on cognitive decline and dementia risk. This evidence concerns the gene ACE and dementia.